Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Kanamycin
2. Kanamycin A
3. Kantrex
1. Kanamycin A Sulfate
2. Kanamycin Monosulfate
3. 25389-94-0
4. Kanamycin Acid Sulfate
5. Kanamycin A Sulphate
6. Kanamycin (sulfate)
7. Ophtalmokalixan
8. 133-92-6
9. Kanamycin Monosulphate
10. 3847-27-6
11. J80ex28smq
12. Kanamycin Monosulfate [jan]
13. Kanamycin A Monosulfate
14. Chebi:6109
15. Nsc-757068
16. (2r,3s,4s,5r,6r)-2-(aminomethyl)-6-[(1r,2r,3s,4r,6s)-4,6-diamino-3-[(2s,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol;sulfuric Acid
17. Dsstox_cid_27524
18. Dsstox_rid_82394
19. Dsstox_gsid_47524
20. Cristalomicina
21. Kanabristol
22. Kanamytrex
23. Otokalixin
24. Cantrex
25. Kanacedin
26. Kanaqua
27. Kanasig
28. Kanatrol
29. Kanescin
30. Kanicin
31. Kannasyn
32. Kantrim
33. Kano
34. (2r,3s,4s,5r,6r)-2-(aminomethyl)-6-(((1r,2r,3s,4r,6s)-4,6-diamino-3-(((2s,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)tetrahydro-2h-pyran-3,4,5-triol Sulfate
35. Kanamycin Sulfate [jan]
36. Unii-j80ex28smq
37. Kanamycin Sulfate [usp:jan]
38. Mfcd00070253
39. Kanamycin Sulfate From Streptomyces Kanamyceticus, Animal Component-free
40. Einecs 223-347-1
41. Einecs 246-933-9
42. Kantrex (tn)
43. Kanamycin, Sulfate (1:1) (salt)
44. Kanamycin Sulfate (tn)
45. Kanamycin Sulfate (usp)
46. Ncgc00016792-01
47. Kanamycin Sulfate Solution
48. Kanamycin Sulfate (jp17)
49. Kanamycin Sulphate (1:1)
50. Cas-25389-94-0
51. Chembl1446
52. Schembl65538
53. Kanamycin Mono Sulfate
54. Kanamycin Monosulfate (jp17)
55. Dtxsid1047524
56. Hms500b06
57. Kuc109575ac
58. Kanamycin A Sulfate [mi]
59. Kanamycin Sulfate [vandf]
60. Hms2096o09
61. Hms3713o09
62. Kanamycin Sulfate [usp-rs]
63. Kanamycin Sulfate [who-dd]
64. D-streptamine, O-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-->6)-o-[6-amino-6-deoxy-alpha-d-glucopyranosyl-(1-->4)]-2-deoxy-, Sulfate (1:1)
65. Ksc-27-052c
66. Tox21_110612
67. Tox21_202817
68. Hy-16566a
69. S2315
70. C18h36n4o11 .h2o4s
71. Akos025310124
72. Kanamycin Sulfate [green Book]
73. Ccg-220394
74. Cs-1140
75. Kanamycin Sulfate [orange Book]
76. Nsc 757068
77. Kanamycin Sulfate [usp Monograph]
78. Ncgc00260363-01
79. Kanamycin Monosulfate, Cell Culture Grade
80. Kanamycin Sulfate 100 Microg/ml In Water
81. Kanamycin Monosulfate [ep Monograph]
82. K0047
83. C08046
84. D00866
85. D03262
86. 133k926
87. Q27107073
88. Kanamycin Sulfate Streptomyces Kanamyceticus, Powder, Gamma-irradiated
89. Kanamycin Sulfate From Streptomyces Kanamyceticus, Meets Usp Testing Specifications, Powder
90. Kanamycin Sulfate, Mixture Of Kanamycin A (main Component) And Kanamycin B And C
91. Kanamycin Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material
92. (2r,3s,4s,5r,6r)-2-(aminomethyl)-6-((1r,2r,3s,4r,6s)-4,6-diamino-3-((2s,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-2-hydroxycyclohexyloxy)tetrahydro-2h-pyran-3,4,5-triol Sulfate
93. (2r,3s,4s,5r,6r)-2-(aminomethyl)-6-[(1r,2r,3s,4r,6s)-4,6-bis(azanyl)-3-[(2s,3r,4s,5s,6r)-4-azanyl-6-(hydroxymethyl)-3,5-bis(oxidanyl)oxan-2-yl]oxy-2-oxidanyl-cyclohexyl]oxy-oxane-3,4,5-triol Sulphate
94. .alpha.-d-glucopyranoside, (1s,2r,3r,4s,6r)-4,6-diamino-3-[(6-amino-6-deoxy-.alpha.-d-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-, Sulfate (1:1) (salt)
95. D-streptamine, O-3-amino-3-deoxy-.alpha.-d-glucopyranosyl(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl(1->4))-2-deoxy-, Sulfate (1:1) (salt)
96. D-streptamine, O-3-amino-3-deoxy-.alpha.-d-glucopyranosyl(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl(1->4))-2-deoxy-, Sulphate (1:1) (salt)
97. D-streptamine, O-3-amino-3-deoxy-alpha-d-glucopyranosyl(1->6)-o-(6-amino-6-deoxy-alpha-d-glucopyranosyl(1->4))-2-deoxy-, Sulfate (1:1) (salt)
98. D-streptamine, O-3-amino-3-deoxy-alpha-d-glucopyranosyl(1-6)-o-(6-amino-6-deoxy-alpha-d-glucopyranosyl(1-4))-2-deoxy-, Sulfate (1:1) (salt)
99. Kanamycin Sulfate From Streptomyces Kanamyceticus, Powder, Bioreagent, Suitable For Cell Culture, Suitable For Plant Cell Culture
100. O-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1->6)-o-[6-amino-6-deoxy-alpha-d-glucopyranosyl-(1->4)]-2-deoxy-d-streptamine Monosulfate
Molecular Weight | 582.6 g/mol |
---|---|
Molecular Formula | C18H38N4O15S |
Hydrogen Bond Donor Count | 13 |
Hydrogen Bond Acceptor Count | 19 |
Rotatable Bond Count | 6 |
Exact Mass | 582.20543769 g/mol |
Monoisotopic Mass | 582.20543769 g/mol |
Topological Polar Surface Area | 366 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 720 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 15 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Kanamycin sulfate |
Active Ingredient | Kanamycin sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 1gm base/3ml; eq 500mg base/2ml |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
2 of 2 | |
---|---|
Drug Name | Kanamycin sulfate |
Active Ingredient | Kanamycin sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 1gm base/3ml; eq 500mg base/2ml |
Market Status | Prescription |
Company | Fresenius Kabi Usa |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-11-30
Pay. Date : 2016-03-08
DMF Number : 28275
Submission : 2014-05-06
Status : Active
Type : II
NDC Package Code : 42513-0002
Start Marketing Date : 2010-08-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13392
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13599
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13628
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13325
Submission : 1998-09-01
Status : Inactive
Type : II
NDC Package Code : 42513-0002
Start Marketing Date : 2010-08-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42513-0002
Start Marketing Date : 2010-08-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Kanamycin Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Kanamycin Sulfate, including repackagers and relabelers. The FDA regulates Kanamycin Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Kanamycin Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Kanamycin Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Kanamycin Sulfate supplier is an individual or a company that provides Kanamycin Sulfate active pharmaceutical ingredient (API) or Kanamycin Sulfate finished formulations upon request. The Kanamycin Sulfate suppliers may include Kanamycin Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Kanamycin Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Kanamycin Sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Kanamycin Sulfate active pharmaceutical ingredient (API) in detail. Different forms of Kanamycin Sulfate DMFs exist exist since differing nations have different regulations, such as Kanamycin Sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Kanamycin Sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Kanamycin Sulfate USDMF includes data on Kanamycin Sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Kanamycin Sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Kanamycin Sulfate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Kanamycin Sulfate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Kanamycin Sulfate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Kanamycin Sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Kanamycin Sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Kanamycin Sulfate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Kanamycin Sulfate suppliers with NDC on PharmaCompass.
Kanamycin Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Kanamycin Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Kanamycin Sulfate GMP manufacturer or Kanamycin Sulfate GMP API supplier for your needs.
A Kanamycin Sulfate CoA (Certificate of Analysis) is a formal document that attests to Kanamycin Sulfate's compliance with Kanamycin Sulfate specifications and serves as a tool for batch-level quality control.
Kanamycin Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Kanamycin Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Kanamycin Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Kanamycin Sulfate EP), Kanamycin Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Kanamycin Sulfate USP).
LOOKING FOR A SUPPLIER?